RecruitingPhase 2NCT03805477

Nintedanib in Patients With Bronchiolitis Obliterans Syndrome Following Hematopoietic Stem Cell Transplantation

Studying Bronchiolitis obliterans

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
University Hospital, Basel, Switzerland
Principal Investigator
Katrin Hostettler Haack, PD Dr. med
Clinic of Respiratory Medicine, University Hospital Basel
Intervention
Nintedanib(drug)
Enrollment
20 enrolled
Eligibility
18 years · All sexes
Timeline
20192026

Study locations (3)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT03805477 on ClinicalTrials.gov

Other trials for Bronchiolitis obliterans

Additional recruiting or active studies for the same condition.

See all trials for Bronchiolitis obliterans

← Back to all trials